US EditionNLS Abstracts Showcase Narcolepsy and Diabetes-Related Sleep Research
Summary by sleepreviewmag.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
NLS Abstracts Showcase Narcolepsy and Diabetes-Related Sleep Research
New preclinical findings on dual orexin receptor agonists for narcolepsy and a multitarget approach to diabetes-related sleep disorders are among abstracts NLS Pharmaceutics submitted to the 2025 Annual Meeting of the ASCP. Summary: NLS Pharmaceutics Ltd has submitted three research abstracts to the 2025 Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP), with two focusing on sleep-related conditions. One abstract prese…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
